223 related articles for article (PubMed ID: 11283054)
1. Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans.
Petrikkou E; Rodríguez-Tudela JL; Cuenca-Estrella M; Gómez A; Molleja A; Mellado E
J Clin Microbiol; 2001 Apr; 39(4):1345-7. PubMed ID: 11283054
[TBL] [Abstract][Full Text] [Related]
2. Standardization of antifungal susceptibility variables for a semiautomated methodology.
Rodríguez-Tudela JL; Cuenca-Estrella M; Díaz-Guerra TM; Mellado E
J Clin Microbiol; 2001 Jul; 39(7):2513-7. PubMed ID: 11427562
[TBL] [Abstract][Full Text] [Related]
3. Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi.
Rodriguez-Tudela JL; Chryssanthou E; Petrikkou E; Mosquera J; Denning DW; Cuenca-Estrella M
J Clin Microbiol; 2003 Nov; 41(11):5236-7. PubMed ID: 14605171
[TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast One.
Carrillo-Muñoz AJ; Quindós G; Ruesga M; del Valle O; Pemán J; Cantón E; Hernández-Molina JM; Santos P
Mycoses; 2006 Jul; 49(4):293-7. PubMed ID: 16784443
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi.
Aberkane A; Cuenca-Estrella M; Gomez-Lopez A; Petrikkou E; Mellado E; Monzón A; Rodriguez-Tudela JL
J Antimicrob Chemother; 2002 Nov; 50(5):719-22. PubMed ID: 12407129
[TBL] [Abstract][Full Text] [Related]
6. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.
Gehrt A; Peter J; Pizzo PA; Walsh TJ
J Clin Microbiol; 1995 May; 33(5):1302-7. PubMed ID: 7615745
[TBL] [Abstract][Full Text] [Related]
7. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.
Meletiadis J; Mouton JW; Meis JF; Bouman BA; Donnelly PJ; Verweij PE;
J Clin Microbiol; 2001 Dec; 39(12):4256-63. PubMed ID: 11724829
[TBL] [Abstract][Full Text] [Related]
8. Comparison of NCCLS and 3-(4,5-dimethyl-2-Thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method.
Meletiadis J; Meis JF; Mouton JW; Donnelly JP; Verweij PE
J Clin Microbiol; 2000 Aug; 38(8):2949-54. PubMed ID: 10921957
[TBL] [Abstract][Full Text] [Related]
9. Inoculum preparation for in-vitro susceptibility testing of filamentous fungi.
Guarro J; Pujol I; Aguilar C; Llop C; Fernández-Ballart J
J Antimicrob Chemother; 1998 Sep; 42(3):385-7. PubMed ID: 9786479
[TBL] [Abstract][Full Text] [Related]
10. Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis.
Qiu WY; Yao YF; Zhu YF; Zhang YM; Zhou P; Jin YQ; Zhang B
Curr Eye Res; 2005 Dec; 30(12):1113-20. PubMed ID: 16354625
[TBL] [Abstract][Full Text] [Related]
11. Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi.
Espinel-Ingroff A; Kerkering TM
J Clin Microbiol; 1991 Feb; 29(2):393-4. PubMed ID: 2007647
[TBL] [Abstract][Full Text] [Related]
12. [In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
Vivas JR; Torres-Rodríguez JM
Rev Esp Quimioter; 2001 Jun; 14(2):191-7. PubMed ID: 11704774
[TBL] [Abstract][Full Text] [Related]
13. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
Heyn K; Tredup A; Salvenmoser S; Müller FM
Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
[TBL] [Abstract][Full Text] [Related]
14. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
[TBL] [Abstract][Full Text] [Related]
15. Activity and post antifungal effect of chlorpromazine and trifluopherazine against Aspergillus, Scedosporium and zygomycetes.
Vitale RG; Afeltra J; Meis JF; Verweij PE
Mycoses; 2007 Jul; 50(4):270-6. PubMed ID: 17576318
[TBL] [Abstract][Full Text] [Related]
16. Antifungal susceptibility and pathogenic potential of environmental isolated filamentous fungi compared with colonizing agents in immunocompromised patients.
Teixeira AB; Silva M; Lyra L; Luz EA; Uno J; Takada H; Miyaji M; Nishimura K; Schreiber AZ
Mycopathologia; 2005 Sep; 160(2):129-35. PubMed ID: 16170608
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility testing methods of antifungal agents.
Ernst EJ
Methods Mol Med; 2005; 118():3-12. PubMed ID: 15888930
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of five antifungal agents against pathogenic Exophiala species.
Li D; Li R; Wang D; Ma S
Chin Med J (Engl); 1999 Jun; 112(6):484-8. PubMed ID: 11601322
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility-testing in Aspergillus species.
Lass-Flörl C; Perkhofer S
Mycoses; 2008 Sep; 51(5):437-46. PubMed ID: 18422914
[TBL] [Abstract][Full Text] [Related]
20. [An update on antifungal susceptibility testing].
Tapia P CV
Rev Chilena Infectol; 2009 Apr; 26(2):144-50. PubMed ID: 19621145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
